AppxG Email to recipients

Appendix G: Email to recipients: OPPE-NCCDPHP-DDT-recipient email-PS23-0020-new-2024-2026-04-15-2024

Greetings,

We are writing to request the annual submission of performance measures for your award under CDC-RFA-DP23-0020 A Strategic Approach to Advancing Health Equity for Priority Populations with or at Risk for Diabetes Cooperative Agreement. Your participation in this information collection is expected as part of the conditions for funding. In this reporting period, we are requesting you to document progress for all performance measures associated with DP23-2320 strategies in your workplan.

These performance measures will be used to monitor progress towards short-term, intermediate, and long-term outcomes as a result of recipient efforts to implement evidence-based diabetes management and type 2 diabetes prevention and risk mitigation strategies.

Recipients should review the Performance Measures Guidance Document before reporting and submitting these data through the Awards Management Platform (AMP).

Evaluation-related resources for performance measure reporting:

• Any support with providing the information requested in the performance measures guidance, timeline, should be directed to the evaluator and project officer assigned to your state/organization. All questions should be submitted through the AMP system Contact Support (cdc.gov).

• For questions and technical issues with reporting in AMP, submit your request to [email protected].

Please complete submission of data by September 30, 2024. If you have any questions, please do not hesitate to reach out to your assigned Evaluator.

Sincerely,

[name]

Only for Component C recipients

Greetings,

We are writing to request the annual submission of performance measures for your award under CDC-RFA-DP23-0020 A Strategic Approach to Advancing Health Equity for Priority Populations with or at Risk for Diabetes Cooperative Agreement. Your participation in this information collection is expected as part of the conditions for funding. In this reporting period, we are requesting you to document progress for all performance measures associated with DP23-2320 strategies in your workplan.

These performance measures will be used to monitor progress towards short-term, intermediate, and long-term outcomes as a result of recipient efforts to implement evidence-based type 2 diabetes prevention and risk mitigation strategies.

Recipients should review the Performance Measures Guidance Document before reporting and submitting these data through the Awards Management Platform (AMP).

Evaluation-related resources for performance measure reporting:

• Any support with providing the information requested in the performance measures guidance, timeline, should be directed to the evaluator and project officer assigned to your state/organization. All questions should be submitted through the AMP system Contact Support (cdc.gov).

• For questions and technical issues with reporting in AMP, submit your request to [email protected].

Please complete submission of data by September 30, 2024. If you have any questions, please do not hesitate to reach out to your assigned Evaluator.

Sincerely,

[name]